Orange, California
Phase 1 cancer trials in Orange, CA
36 Phase 1 cancer studies are recruiting participants at sites in Orange as of November 17, 2026, according to ClinicalTrials.gov. Phase 1 Cancer Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Orange at a glance
- 36 studies are recruiting at a site in Orange.
- By phase: Early Phase 1 (2), Phase 1 (17), Phase 1/2 (17).
- By sponsor: industry (23), university, hospital or other (8), government (5).
- By research area: Lung Cancer (9), Lymphoma (9), Breast Cancer (6), Pancreatic Cancer (6), Melanoma (3), Prostate Cancer (3).
- Most recent update to one of these records: November 17, 2026.
Breast cancer studies recruiting in Orange
Basic details from each study's public record (the 30 most recently updated of 36). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Boehringer Ingelheim
- Study site
- University of California Irvine
- Registry record
- NCT06324357 · updated
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Astellas Pharma Global Development, Inc.
- Study site
- UC Irvine Health-Chao Family Comprehensive Cancer Center
- Registry record
- NCT07488676 · updated
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- SystImmune Inc.
- Study site
- University of California Irvine Medical Center
- Registry record
- NCT05983432 · updated
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Seagen, a wholly owned subsidiary of Pfizer
- Study site
- UC Irvine Health - Chao Family Comprehensive Cancer Center
- Registry record
- NCT05208762 · updated
Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- University of California, Irvine
- Study site
- Chao Family Comprehensive Cancer Center University of California, Irvine
- Registry record
- NCT07064018 · updated
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Day One Biopharmaceuticals, Inc.
- Study site
- UC Irvine Health-Chao Family Comprehensive Cancer Center
- Registry record
- NCT05377996 · updated
Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Orange, CA on ClinicalTrials.gov.
Lung cancer studies recruiting in Orange
A Study of VET3-TGI in Patients With Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- KaliVir Immunotherapeutics
- Study site
- UC Irvine Health
- Registry record
- NCT06444815 · updated
Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Boehringer Ingelheim
- Study site
- University of California Irvine
- Registry record
- NCT04886804 · updated
A 2-part Phase 1/2 Open-label Trial on ODM-212
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Orion Corporation, Orion Pharma
- Study site
- UC Irvine Health
- Registry record
- NCT07563738 · updated
A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Astellas Pharma Global Development, Inc.
- Study site
- University of California - Irvine
- Registry record
- NCT07140016 · updated
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Revolution Medicines, Inc.
- Study site
- UC IRVINE Health
- Registry record
- NCT06128551 · updated
A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- AbbVie
- Study site
- University Of California Irvine Medical Center /ID# 270507
- Registry record
- NCT06858813 · updated
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Plexium, Inc.
- Registry record
- NCT07284186 · updated
Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Orange, CA on ClinicalTrials.gov.
Prostate cancer studies recruiting in Orange
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
- Phase 1
- Ages 18 and older
- Male participants
- Sponsor
- Astellas Pharma Global Development, Inc.
- Study site
- UCI Health Chao Family Comprehensive Cancer Center
- Registry record
- NCT05997615 · updated
A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- University of California-Irvine Medical Center ( Site 0016)
- Registry record
- NCT06863272 · updated
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer
- Phase 1/2
- Ages 18 and older
- Male participants
- Sponsor
- Shenzhen Ionova Life Sciences Co., Ltd.
- Study site
- UC Irvine Medical Center
- Registry record
- NCT06609005 · updated
Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Orange, CA on ClinicalTrials.gov.
Melanoma studies recruiting in Orange
MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma
- Phase 1/2
- Ages 18 to 90
- All sexes
- Sponsor
- Perspective Therapeutics
- Study site
- University of California Irvine
- Registry record
- NCT05655312 · updated
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Phase 1/2
- From 12 months, up to 30 years
- All sexes
- Sponsor
- Children's Oncology Group
- Study site
- Children's Hospital of Orange County
- Registry record
- NCT04851119 · updated
Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors
- Early Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- University of California, Irvine
- Study site
- Chao Family Comprehensive Cancer Center, University of California, Irvine
- Registry record
- NCT07628634 · updated
Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in Orange, CA on ClinicalTrials.gov.
Lymphoma studies recruiting in Orange
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Phase 1/2
- Up to age 22
- All sexes
- Sponsor
- PedAL BCU, LLC
- Study site
- Children's Hospital of Orange County
- Registry record
- NCT04726241 · updated
TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
- Phase 1/2
- Up to age 1
- All sexes
- Sponsor
- Tanja Andrea Gruber
- Study site
- Children's Hospital of Orange County
- Registry record
- NCT05848687 · updated
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
- Phase 1/2
- Ages 12 and older
- All sexes
- Sponsor
- Nuvalent Inc.
- Study site
- University of California Irvine Medical Center
- Registry record
- NCT05384626 · updated
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- UC Irvine Health/Chao Family Comprehensive Cancer Center
- Registry record
- NCT06860594 · updated
Testing the Effect of Teclistamab on Recurrent Plasmablastic Lymphoma
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- UC Irvine Health/Chao Family Comprehensive Cancer Center
- Registry record
- NCT07332507 · updated
Testing the Safety of Anti-Cancer Drug, CX-5461 (Pidnarulex), in Treating Lymphoma With Specific Changes in the MYC Gene
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- UC Irvine Health/Chao Family Comprehensive Cancer Center
- Registry record
- NCT07069699 · updated
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
- Phase 1/2
- From 12 months, up to 21 years
- All sexes
- Sponsor
- Children's Oncology Group
- Study site
- Children's Hospital of Orange County
- Registry record
- NCT04870944 · updated
Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma
- Early Phase 1
- Ages 1 to 31
- All sexes
- Sponsor
- New York Medical College
- Study site
- Children's Hospital Orange County
- Registry record
- NCT03719105 · updated
Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Orange, CA on ClinicalTrials.gov.
Pancreatic cancer studies recruiting in Orange
Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- UC Irvine Health/Chao Family Comprehensive Cancer Center
- Registry record
- NCT05372614 · updated
Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- UC Irvine Health/Chao Family Comprehensive Cancer Center
- Registry record
- NCT05687123 · updated
A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Astellas Pharma Global Development, Inc.
- Study site
- University of California Irvine Medical Center
- Registry record
- NCT05365581 · updated
Source: ClinicalTrials.gov. Data processed . See every pancreatic cancer study recruiting in Orange, CA on ClinicalTrials.gov.
Ask about studies near Orange
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in California
All California locations
377 studies recruiting across 44 cities.
Los Angeles
156 studies recruiting.
Duarte
109 studies recruiting.
San Francisco
66 studies recruiting.
La Jolla
37 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.
Phase 1 Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections